Organosulfur compounds for the prevention and treatment of neurodegenerative diseases
AssigneeAllium Vitalis Incorporated
InventorDavid Michael Ott
Life of this patent
Estimating the term…
Abstract
Organosulfur compounds and compositions are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein aggregates, and the resulting neuroinflammation. Various neurodegenerative diseases which are suitable for treatment using these compositions include Alzheimer's disease, senile dementia, Parkinson's disease, multiple sclerosis, Lewy body disease, peripheral neuropathy, spinal cord injury, traumatic brain injury, stroke and cerebral ischemia.
Claims15
The medicinal compound S-(3-((2-acetamido-2-carboxyethyl)-disulfanyl)propyl)-N-acetylcysteine or salts thereof.
The medicinal compound S-(1-((2-acetamido-2-carboxyethyl)-disulfanyl)propan-2-yl)-N-acetylcysteine or salts thereof.
Dependencies are inferred from the claim text.